|
2025
|
P/S
|
Transdermal contraceptives; contraceptives; hormone preparations; pharmaceutical and medical prep... |
|
|
P/S
|
Transdermal contraceptives. |
|
|
P/S
|
Transdermal contraceptives |
|
|
P/S
|
Providing information relating to diagnostic, prophylactic and therapeutic properties of pharmace... |
|
2024
|
Invention
|
Solid oral pharmaceutical compositions including co‑processed nitrosamine inhibitor and microcrys... |
|
|
Invention
|
Solid oral pharmaceutical compositions including a nitrosamine inhibitor including mannitol. The ... |
|
|
P/S
|
Downloadable mobile application for providing information on pharmaceutical preparations |
|
|
P/S
|
Steroid-antibiotic preparations |
|
|
Invention
|
Solid oral pharmaceutical compositions including alkyl 3,4,5-trihydroxybenzoate as a nitrosamine ... |
|
|
Invention
|
Solid oral pharmaceutical compositions including alkyl 3,4,5‑trihydroxybenzoate as a nitrosamine ... |
|
2023
|
P/S
|
Pharmaceutical preparations for the treatment of multiple sclerosis. |
|
|
P/S
|
Pharmaceutical preparations for the treatment of multiple sclerosis; pharmaceutical preparations ... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of multiple sclerosis |
|
|
P/S
|
Pharmaceutical preparations for the treatment of multiple sclerosis |
|
|
P/S
|
Pharmaceutical preparations for the treatment of thyroid disorders |
|
|
P/S
|
Pharmaceutical preparations for the treatment of asthma in patients 6 years of age and older and ... |
|
2020
|
Invention
|
Method for the purification of g-csf.
The present invention relates to a method for obtaining re... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of diabetes. |
|
|
P/S
|
Pharmaceutical preparations for the treatment of diabetes. |
|
|
P/S
|
Inhalers for respiratory ailments; inhalers pre-filled with
pharmaceutical preparations for the ... |
|
|
P/S
|
Inhalers for respiratory ailments; inhalers pre-filled with pharmaceutical preparations for the t... |
|
2019
|
P/S
|
Pharmaceutical preparations for the treatment of multiple
sclerosis. |
|
|
P/S
|
Inhalers pre-filled with pharmaceutical preparations for the treatment of respiratory ailments In... |
|
|
Invention
|
Process of making regadenoson and novel polymorphs thereof. Novel processes for making the N-pyrr... |
|
|
P/S
|
Transdermal contraceptives. |
|
|
P/S
|
Pharmaceutical preparations for the treatment of Non Hodgkin's Lymphoma (NHL) and Chronic Lymphoc... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of multiple sclerosis. |
|
|
P/S
|
Pharmaceutical preparations for treatment of respiratory ailments. Inhalers for respiratory ailme... |
|
|
P/S
|
Pharmaceutical preparations for treatment of respiratory ailments.
Inhalers for respiratory ailme... |
|
|
P/S
|
Pharmaceutical preparations for treatment of respiratory ailments Inhalers for respiratory ailments |
|
2018
|
P/S
|
Inhalers for respiratory ailments |
|
|
P/S
|
Pharmaceutical preparations for treatment of respiratory ailments |
|
|
P/S
|
Patient support services, namely, providing information to patients relating to diagnostic, proph... |
|
|
Invention
|
Sincalide formulations and methods of use.
The present invention relates to improved Sincalide r... |
|
|
P/S
|
Pharmaceuticals preparations for the treatment of diabetes. |
|
|
Invention
|
Polymorphs of ponatinib hydrochloride. Novel crystalline ponatinib hydrochloride forms designated... |
|
2017
|
Invention
|
Process and novel polymorphic form of vortioxetine and its pharmaceutically acceptable salts. Pro... |
|
|
Invention
|
Polymorph of regadenoson and process for preparation thereof. Processes are provided for the prep... |
|
|
Invention
|
Processes for making ponatinib and intermediates thereof.
Methods are disclosed for making 3-(im... |
|
|
Invention
|
Methods of making carfilzomib and intermediates thereof.
Racemization-free methods are disclosed... |
|
|
Invention
|
Process for preparation and purification of pomalidomide.
Processes are disclosed for making pom... |
|
2016
|
Invention
|
Methods of making netupitant and intermediates thereof.
Methods are disclosed for the preparatio... |
|
|
Invention
|
Methods of making carfilzomib and intermediates thereof. Racemization-free methods are disclosed ... |
|
|
Invention
|
Processes for making ponatinib and intermediates thereof. Methods are disclosed for making 3-(imi... |
|
|
Invention
|
Process of making regadenoson and novel polymorph thereof. Novel processes for making the N-pyrra... |
|
2015
|
Invention
|
Processes for making ponatinib and intermediates thereof. Novel synthetic approaches to make 3-(i... |
|
2014
|
Invention
|
Process for preparing heparinoids and intermediates useful in the synthesis thereof.
Processes a... |
|
|
Invention
|
Processes for making ponatinib and intermediates thereof.
Novel synthetic approaches to make 3-(... |
|
2013
|
Invention
|
Bronchodilating beta-agonist compositions and methods. Bronchodilating compositions and methods a... |
|
|
Invention
|
Fentanyl suspension-based silicone adhesive formulations and devices for transdermal delivery of ... |
|
2009
|
Invention
|
Transdermal systems containing multilayer adhesive matrices to modify drug delivery. A transderma... |
|
|
Invention
|
Extended release formulation containing a wax.
Extended release pharmaceutical formulations are ... |
|
|
Invention
|
Extended release forumulation containing a wax. Extended release pharmaceutical formulations are ... |
|
|
Invention
|
Controlled release budesonide minitablets. Embodiments of a controlled release minitablet compris... |
|
2008
|
Invention
|
Extended-release dosage form. Provided are pharmaceutical formulations comprising sustained relea... |
|
2007
|
Invention
|
Stabilized tolterodine tartrate formulations. A pharmaceutical composition contains tolterodine L... |
|
|
Invention
|
Drug formulations having inert sealed cores. A drug composition comprising a coated bead is used ... |
|
|
Invention
|
Extended-release dosage form.
Provided are pharmaceutical formulations comprising sustained rele... |
|
|
Invention
|
Storage stable thyroxine active drug formulations and methods for their production.
This inventi... |
|
2005
|
Invention
|
Storage stable thyroxine active drug formulations and methods for their production. This inventio... |
|
2004
|
Invention
|
Novel orally administrable formulation of nitrofurantoin and a method for preparing said formulat... |
